Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Adult T-cell leukemia/lymphoma" to "[[Category:Adult T-cell leukemia-lymphoma") |
m (→Also known as) |
||
| Line 136: | Line 136: | ||
|Pulmison | |Pulmison | ||
|- | |- | ||
| + | |Rayos | ||
|Rectodelt | |Rectodelt | ||
|Senterlic | |Senterlic | ||
| Line 143: | Line 144: | ||
|Trolic | |Trolic | ||
|Ultracorten | |Ultracorten | ||
| + | |- | ||
|Vitazon | |Vitazon | ||
| − | |||
|Winpred | |Winpred | ||
| − | |||
| | | | ||
| | | | ||
Revision as of 14:32, 26 June 2021
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- Immune thrombocytopenia (ITP)
- B-cell acute lymphoblastic leukemia
- Burkitt lymphoma
- Chronic lymphocytic leukemia
- Acquired coagulopathy
- Diffuse large B-cell lymphoma
- Erdheim-Chester disease
- Follicular lymphoma
- HIV-associated lymphoma
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Hodgkin lymphoma
- Langerhans cell histiocytosis
- Large granular lymphocytic leukemia
- Light-chain (AL) amyloidosis
- Mantle cell lymphoma
- Marginal zone lymphoma
- Mast cell diseases
- Mediastinal gray-zone lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
- Myelofibrosis
- Peripheral T-cell lymphoma
- Post-transplant lymphoproliferative disorder
- Primary mediastinal B-cell lymphoma
- Prostate cancer
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Waldenström macroglobulinemia
Diseases for which it was used
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
Also known as
- Generic names: pred
- Brand names:
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| Artinizona | Artrizona | Becortem | Bersen | Colisone | Cortancyl | Corticorten | Cortigen |
| Cortiol | Cortiprex | Cutason | Dacortin | Decortancyl | Decortin | Decortisyl | Dehydrocortison |
| Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan | Deltacortene | Deltacortone | Deltason | Deltasone |
| Deltisona | Dispersona | Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten |
| Hostacortin | Ifison | Isolone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednisona | Prednisonum |
| Prednitone | Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison |
| Rayos | Rectodelt | Senterlic | Sone | Steerometz | Sterapred | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drugs
- Oral medications
- Immunosuppressants
- Steroids
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia medications
- Acquired coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenia medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- Light-chain (AL) amyloidosis medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- FDA approved in 1955